Многоликий ринит: современный взгляд на диагностику и алгоритм лечения

Риниты относятся к широко распространенным заболеваниям и нередко являются начальным ключевым звеном в формировании респираторной патологии как верхних, так и нижних дыхательных путей. В данном обзоре представлена информация о важности аналитического подхода к определению факторов риска, фенотипической классификации, критериям диагноза и терапии неаллергического ринита.

1. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2)LEN and AllerGen) // Allergy. 2008; 63, Suppl. 86: 8–160.

2. Brozek J. L., Bousquet J., Baena-Cagnani C. E., Bonini S., Canonica G. W., Casale T. B., van Wijk R. G., Ohta K., Zuberbier T., Scheunemann H. J. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision // J Allergy Clin Immunol. 2010; 126: 466–476.

3. Bousquet J., Schunemann H. J., Fonseca J. et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation // Allergy. 2015; 70: 1372–1392.

4. Brozek J. L., Bousquet J., Agache I. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines — 2016 Revision // J Allergy Clin Immunol. 2017; 140 (4): 950–958.

5. Papadopoulos N. G., Bernstein J. A., Demoly P., Dykewicz M., Fokkens W., Hellings P. W., Peters A. T., Rondon C., Togias A., Cox L. S. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report // Allergy. 2015; 70: 474–494.

6. Akdis C. A., Hellings P. W., Agache I. / Ed. Global Atlas of Allergic Rhinitis and Chronic Rhinosinusitis. Published by the European Academy of Allergy and Clinical Immunology, 2015, Р. 232–233.

7. Hellings P. W., Klimek L., Cingi C. et al. Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology // Allergy. 2017; 72: 1657–1665.

8. Fokkens W. J., Lund V. J., Mullol J. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012 // Rhinology. 2012; 50, Suppl. 23: 1–298.

9. Хаитов Р. М., Ильина Н. И. Аллергология. Федеральные клинические рекомендации. М.: Фармарус Принт Медиа, 2014. С. 20–34.

10. Федеральные клинические рекомендации по диагностике и лечению аллергического ринита. [Электронный ресурс]. 2013. URL: http://www.raaci.ru/klinicheskie-rekomendacii/.

11. Shah R., McGrath K. G. Chapter 6: Nonallergic rhinitis // Allergy Asthma Proc. 2012. May-Jun; 33 Suppl 1: S19–21.

12. Bousquet J., Bachert C., Canonica G. W. Unmet needs in severe chronic upper airway disease (SCUAD) // J Allergy Clin Immunol. 2009, Sep; 124 (3): 428–433.

13. Roberts G., Xatzipsalti M., Borrego L. et al. Paediatric rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology // Allergy. 2013; 68: 1102–1116.

14. WHO Collaborating Center for Asthma and Rhinitis, Bousquet J., Anto J. M., Demoly P., Schunemann H. J., Togias A., Akdis M. et al, Severe chronic allergic (and related) diseases: a uniform approach — a MeDALL — GA2 LEN — ARIA position paper // Int Arch Allergy Immunol. 2012; 158: 216–231.

15. Nassef M., Shapiro G., Casale T. B. Identifying and managing rhinitis and its subtypes: allergic and nonallergic components — a consensus report and materials from the Respiratory and Allergic Disease Foundation // Curr Med Res Opin. 2006; 22 (12): 2541–2548.

16. L?tvall J., Akdis C. A., Bacharier L. B. et al. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome // The Journal of Allergy and Clinical Immunology. 2011; 127 (2): 355–360.

17. Sin B., Togias A. Pathophysiology of allergic and nonallergic rhinitis // Proc Am Thorac Soc. 2011, Mar; 8 (1): 106-11-41.

18. Wilson K. F., Spector M. E., Orlandi R. R. Types of rhinitis // Otolaryngol Clin North Am. 2011, Jun; 44 (3): 549–559.

19. Moore W. C., Bleecker E. R., Curran-Everett D. et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program // J Allergy Clin Immunol. 2007; 119: 405–413.

20. Haldar P., Pavord I., Shaw D. et al. Cluster analysis and clinical asthma phenotypes // Am J Respir Crit Care Med. 2008; 178: 218–224.

21. Westman M., Kull I., Lind T., Melen E., Stj€arne P., Toskala E., Wickman M., Bergstrom A. The link between parental allergy and offspring allergic and nonallergic rhinitis // Allergy. 2013; 68: 1571–1578.

22. Wallace D. V., Dykewicz M. S., Kaliner M. A. Classification of nonallergic rhinitis syndromes with a focus on vasomotor rhinitis, proposed to be known henceforth as nonallergic rhinopathy // World Allergy Organiz J. 2009; 2: 98–101.

23. Kaliner M. A. Nonallergic rhinopathy (formerly known as vasomotor rhinitis) // Immunol Allergy Clin North Am. 2011 Aug; 31 (3): 441–455.

24. Togias A. Nonallergic rhinitis. In: Akdis C. A., Hellings P. W., Agache I. editors. Spain: Global Atlas of Allergic Rhinitis and Chronic Rhinosinusitis, 2015: 234–236.

25. Tran N. P., Vickery J., Blaiss M. S. Management of rhinitis: allergic and non-allergic // Allergy Asthma Immunol Res. 2011, Jul; 3 (3): 148–156.

26. Rondon C., Campo P., Galindo L. et al. Prevalence and clinical relevance of local allergic rhinitis // Allergy. 2012 Oct; 67 (10): 1282–1288.

27. Patel P. N., Oyefara B., Aarstad R., Bahna S. L. Rhinorrhea not responding to nasal corticosteroids // Allergy Asthma Proc. 2007; 28: 735–738.

28. Poddighe D., Gelardi M., Licari A., del Giudice M. M., Marseglia G. L. Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management // World J Methodol. 2016; 6 (4): 200–213.

29. Jacobs R. L., Freedman P. M., Boswell R. N. Nonallergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation // J Allergy Clin Immunol. 1981; 67: 253–262.

30. Gelardi M., Maselli del Giudice A., Fiorella M. L., Fiorella R., Russo C.., Soleti P., Di Gioacchino M., Ciprandi G. Non-allergic rhinitis with eosinophils and mast cells constitutes a new severe nasal disorder // Int J Immunopathol Pharmacol. 2008; 21: 325–331.

31. Becker S., Rasp J., Eder K., Berghaus A., Kramer M. F., Gr?ger M. Non-allergic rhinitis with eosinophilia syndrome is not associated with local production of specific IgE in nasal mucosa // Eur Arch Otorhinolaryngol. 2016; 273: 1469–1475.

32. Powe D. G., Groot Kormelink T., Sisson M., Blokhuis B. J., Kramer M. F., Jones N. S., Redegeld F. A. Evidence for the involvement of free light chain immunoglobulins in allergic and nonallergic rhinitis // J Allergy Clin Immunol. 2010; 125: 139–145.

33. Global Alliance against Chronic Respiratory Diseases. www.who.int/gard.

34. Bousquet J., Khaltaev N., Cruz A. A. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2 LEN and AllerGen) // Allergy. 2008; 63 (Suppl 86): 8–160.

35. Blaiss M. S. Allergic rhinitis: Direct and indirect costs // Allergy Asthma Proc. 2010; 31: 375–380.

36. Bousquet J., Fokkens W., Burney P. et al. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2 LEN paper // Allergy. 2008; 63: 842–853.

37. Canonica G. W., Bousquet J., Mullol J., Scadding G. K., Virchow J. C. A survey of the burden of allergic rhinitis in Europe // Allergy. 2007; 62 Suppl 85: 17–25.

38. Settipane R. A., Kaliner M. A. Chapter 14: Nonallergic rhinitis // Am J Rhinol Allergy. 2013 May-Jun; 27 Suppl 1: S48–51.

39. Berger W. E., Schonfeld J. E. Nonallergic rhinitis in children // Curr Allergy Asthma Rep. 2007; 7: 112–116.

40. Topal E., Bakirtas A., Yilmaz O., Karag?l I. H., Arslan U., Arga M., Demirsoy M. S., Turktas I. Predictive factors to differentiate between allergic and nonallergic rhinitis in children // Int Forum Allergy Rhinol. 2014; 4: 447–452.

41. Chiang W. C., Chen Y. M., Tan H. K., Balakrishnan A., Liew W. K., Lim H. H., Goh S. H., Loh W. Y., Wong P., Teoh O. H., Goh A., Chay O. M. Allergic rhinitis and non-allergic rhinitis in children in the tropics: prevalence and risk associations // Pediatr Pulmonol. 2012; 47 (10): 1026–1033.

42. Westman M., Stj€arne P., Asarnoj A. et al. Natural course and comorbidities of allergic and nonallergic rhinitis in children // J Allergy Clin Immunol. 2012; 129: 403–408.

43. Bachert C., van Cauwenberge P., Olbrecht J., van Schoor J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium // Allergy. 2006; 61: 693–698.

44. Chuchalin А., Khaltaev N., Antonov N. S. et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation // Int J Chron Obstruct Pulmon Dis. 2014; 9: 963–974.

45. Астафьева Н. Г., Удовиченко Е. Н., Гамова И. В. и др. Пыльцевая аллергия в Саратовской области // РАЖ. 2010, № 1, с. 17–25.

46. Перфилова И. А. Аллергические риноконъюнктивиты в Саратовской области: клинико-эпидемиологические особенности и эффективность фармакотерапии топическими препаратами. Автореф. дис. канд. мед. наук. Саратов, 2011.

47. Астафьева Н. Г., Удовиченко Е. Н., Гамова И. В., Перфилова И. А., Наумова О. С. Кенесариева Ж. М., Вачугова Л. К., Гапон М. С. Аллергические и неаллергические риниты: сравнительная характеристика (часть 2) // Лечащий Врач. 2013, № 5, с. 58–65.

48. Астафьева Н. Г., Удовиченко Е. Н., Гамова И. В., Перфилова И. А. Лечение симптомов неаллергического ринита: оценка эффективности, безопасности и клинической эквивалентности генерика, содержащего флутиказона пропионата // Лечащий Врач. 2012, № 9, с. 91–95.

49. Astafieva N., Kobzev D., Gamova I., Perfilova I., Udovichenko E. Efficacy and safety of fluticasone propionate and its generic among patients with nonallergic rhinopathy // Allergy. 2012, vol. 67, suppl. 96.

50. WAO White Book on Allergy, 2011–2012. Executive Summar. World Allergy Organization. 2013.

51. Pawankar R., Canonica G. W., Holgate S. T., Lockey R. F., Blaiss M. The WAO White Book on Allergy: Update 2013. www.worldallergy.org.

52. Benninger M. S., Benninger R. M. The impact of allergic rhinitis on sexual activity, sleep, and fatigue // Allergy Asthma Proc. 2009; 30 (4): 358–365.

53. Vandenplas O., Vinnikov D., Blanc P. D. et al. Impact of Rhinitis on Work Productivity: A Systematic Review // J Allergy Clin Immunol Pract. 2017 Oct 7. pii: S2213–2198 (17)30725–0.

54. Stull D. E., Roberts L., Frank L., Heithoff K. Relationship of nasal congestion with sleep, mood, and productivity // Curr Med Res Opin. 2007; 23 (4): 811–819.

55. Leynaert B., Neukirch C., Liard R., Bousquet J., Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults // Am J Respir Crit Care Med. 2000; 162 (4 Pt 1): 1391–1396.

56. Meltzer E. O., Nathan R., Derebery J. et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey // Allergy Asthma Proc. 2009; 30 (3): 244–54.

57. Bousquet J., Bewick M., Arnavielhe S. et al. Work productivity in rhinitis using cell phones: The MASK pilot study // Allergy. 2017; 72: 1475–1484.

58. Gelardi M., Iannuzzi L., Tafuri S., Passalacqua G., Quaranta N. Allergic and non-allergic rhinitis: relationship with nasal polyposis, asthma and family history // Acta Otorhinolaryngol Ital. 2014; 34 (1): 36–41.

59. Lee K., Yum H., Sheen Y. et al. Comorbidities and Phenotypes of Rhinitis in Korean Children and Adolescents: A Cross-sectional, Multicenter Study // Allergy Asthma Immunol Res. 2017; 9 (1): 70–78.

60. Астафьева Н. Г., Удовиченко Е. Н., Гамова И. В., Перфилова И. А., Наумова О. С., Кенесариева Ж. М., Вачугова Л. К., Гапон М. С. Аллергические и неаллергические риниты: сравнительная характеристика (часть 1) // Лечащий Врач. 2013, № 4, с. 10–12.

61. Kowalski M. L., Asero R., Bavbek S. et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs // Allergy. 2013; 68: 1219–1232.

62. Астафьева Н. Г., Гамова И. В., Кобзев Д. Ю., Удовиченко Е. Н., Перфилова И. А., Михайлова И. Э. Нестероидные противовоспалительные препараты как причины обострения астмы и других респираторных заболеваний: диагностика и лечение (часть 1) // Лечащий Врач. 2016, № 4, c. 7–12.

63. Астафьева Н. Г., Гамова И. В., Кобзев Д. Ю., Удовиченко Е. Н., Перфилова И. А., Михайлова И. Э. Нестероидные противовоспалительные препараты как причины обострения астмы и других респираторных заболеваний: диагностика и лечение (часть 2) // Лечащий Врач. 2016, № 5, c. 82–88.

64. Szczeklik A., Picado C. Aspirin-induced asthma // Eur Respir Mon. 2003; 23: 239–248.

65. Astafieva N. G. Platelet role in pathogenesis of atopic and nonimmunologic asthma // Allergol Immunopathol. 1990; 18 (1): 19–26.

66. Laidlaw T. M., Kidder M. S., Bhattacharyya N. et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes // Blood. 2012; 119: 3790–3798.

67. Mitsui C., Kajiwara K., Hayashi H., Ito J., Mita H., Ono E., Higashi N., Fukutomi Y., Sekiya K., Tsuburai T., Akiyama K., Yamamoto K., Taniguchi M. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease // J Allergy Clin Immunol. 2016; 137 (2): 400–411.

68. Laidlaw T. M., Boyce J. A. Platelets in patients with aspirin-exacerbated respiratory disease // J Allergy Clin Immunol. 2015; 135 (6): 1407–1414.

69. Schroer B., Pien L. C. Nonallergic rhinitis: common problem, chronic symptoms // Cleve Clin J Med. 2012; 79: 285–293.

70. Varghese M., Glaum M. C., Lockey R. F. Drug-induced rhinitis // Clin Exp Allergy. 2010; 40: 381–384.

71. Subramanian H., Gupta K., Ali H. Roles of Mas-related G proteincoupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases // J Allergy Clin Immunol. 2016; 138: 700–710.

72. Knipping S., Holzhausen H., Goetze G., Riederer A., Bloching M. B. Rhinitis medicamentosa: electron microscopic changes of human nasal mucosa // Otolaryngol Head Neck Surg. 2007; 136: 57–61.

73. Vaidyanathan S., Williamson P., Clearie K., Khan F., Lipworth B. Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion // Am J Respir Crit Care Med. 2010; 182: 19–24.

74. Ellegard E., Hellgren M., Toren K., Karlsson G. The incidence of pregnancy rhinitis // Gynecol Obstet Invest. 2000; 49: 98–101.

75. Ellegard E. K. Clnical and pathogenetic characteristics of pregnancy rhinitis // Clin Rev Allergy Immunol. 2004; 26: 149–159.

76. Hamano N., Terada N., Maesako K. et al. Expression of histamine receptors in nasal epithelial cells and endothelial cells — the effects of sex hormones // Int Arch Allergy Immunol. 2008; 115: 220–227.

77. Navarrete-Palacios E., Hudson R., Reyes-Guerrero G., Guevara-Guzm?n R. Correlation between cytological characteristics of the nasal epithelium and the menstrual cycle // Arch Otolaryngol Head Neck Surg. 2003; 129: 460–463.

78. Wallace D. V., Dykewicz M. S., Bernstein D. I. et al. The diagnosis and management of rhinitis: an updated practice parameter // J Allergy Clin Immunol. 2008; 122: 1–84.

79. EAACI position paper on occupational rhinitis. Moscato G., Pala G., Cullinan P. et al. EAACI Position Paper on assessment of cough in the workplace // Allergy. 2014; 69 (3): 292–304.

80. Nozad C. H., Michael L. M., Betty Lew D., Michael C. F. Non-allergic rhinitis: a case report and review // Clin Mol Allergy. 2010; 8: 1.

81. Graham D., Henderson F., House D. Neutrophil influx measured in nasal lavages of humans exposed to ozone // Arch Environ Health. 1988; 43: 228–233.

82. Malmberg H., Grahne B., Holopainen E., Binder E. Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients // Clin Otolaryngol Allied Sci. 1983; 8: 273–276.

83. deShazo R. D., Stringer S. Atrophic rhinosinusitis: progress toward explanation of an unsolved medical mystery // Curr Opin Allergy Clin Immunol. 2011; 11: 1–7.

84. Georgalas C., Jovancevic L. Gustatory rhinitis // Curr Opin Otolaryngol Head Neck Surg. 2012; 20: 9–14.

85. Waibel K. H., Chang C. Prevalence and food avoidance behaviors for gustatory rhinitis // Ann Allergy Asthma Immunol. 2008; 100: 200–205.

86. Мушкамбаров Н. Н., Кузнецов С. Л. Молекулярная биология. М., 2008.

87. Baroody F. M. Nonallergic Rhinitis: Mechanism of Action // Immunol Allergy Clin North Am. 2016; 36: 279–287.

88. Bernstein J. A., Singh U. Neural Abnormalities in Nonallergic Rhinitis // Curr Allergy Asthma Rep. 2015; 15: 18.

89. Singh U., Bernstein J. A., Haar L., Luther K., Jones W. K. Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis // Am J Rhinol Allergy. 2014; 28: 215–224.

90. Ильина Н. И., Феденко Е. С., Курбачева О. М. Аллергический ринит. Пособие для врачей общей практики и фармацевтов // Российский аллергологический журнал. Приложение к № 3, 2010.

91. Клинические рекомендации. Вазомоторный ринит: патогенез, диагностика и принципы лечения/Под ред. А. С. Лопатина. [Электронный ресурс]. 2014. URL: rhinology.ru/wp-content/uploads/2014/05/vazomotor_14.docx.

92. Федеральные клинические рекомендации по диагностике и лечению аллергического ринита. М., 2013. С. 19.

93. Boumiza R., Debard A.-L., Monneret G. The basophil activation test by flow cytometry: recent developments in clinical studies, standartization and emerging perspectives // Clinical and Molecular Allergy. 2005; 3: 9–23.

94. Scadding G., Hellings P., Alobid I. et al. Diagnostic tools in Rhinology EAACI position paper // Clin Transl Allergy. 2011; 1: 2.

95. Van Gerven L., Boeckxstaens G., Hellings P. Up-date on neuroimmune mechanisms involved in allergic and non-allergic rhinitis // Rhinology. 2012; 50: 227–235.

96. Rondon C., Fernandez J., Lopez S. et al. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis // J Allergy Clin Immunol. 2009; 124: 1005–1011.

97. Incorvaia C., Fuiano N., Martignago I., Gritti B. L., Ridolo E. Local allergic rhinitis: evolution of concepts // Clin Transl Allergy. 2017; Nov 2; 7: 38.

98. Rondon C., Campo P., Eguiluz-Gracia I. et al. Local allergic rhinitis is an independent rhinitis phenotype: the results of a 10-year follow-up study // Allergy. 2018; 73 (2): 470–478.

99. Scadding G. K., Scadding G. W. Diagnosing Allergic Rhinitis // Immunol Allergy Clin North Am. 2016; 36: 249–260.

100. Jacobs R., Lieberman P., Kent E., Silvey M., Locantore N., Philpot E. E. Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment // Allergy Asthma Proc. 2009; 30: 120–127.

101. Gehanno P., Deschamps E., Garay E., Baehre M, Garay R. P. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo // ORL J Otorhinolaryngol Relat Spec. 2001; 63: 76–81.

102. Banov C. H., Lieberman P. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis // Ann Allergy Asthma Immunol. 2001; 86: 28–35.

103. Micheletto C., Tognella S., Visconti M., Pomari C., Trevisan F., Dal Negro R. W. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo // Allergy. 2004; 59: 289–294.

104. Greiner A. N., Meltzer E. O. Overview of the treatment of allergic rhinitis and nonallergic rhinopathy // Proc Am Thorac Soc. 2011; 8: 121–131.

105. Ural A., Oktemer T. K., Kizil Y., Ileri F., Uslu S. Impact of isotonic and hypertonic saline solutions on mucociliary activity in various nasal pathologies: clinical study // J Laryngol Otol. 2009; 123: 517–521.

106. Mygind N., Borum P. Anticholinergic treatment of watery rhinorrhea // Am J Rhinology 1990; 4: 1–5.

107. Fokkens W., Hellings P., Segboer C. Capsaicin for rhinitis // Curr Allergy Asthma Rep. 2016; 16: 60.

108. Holland C., van Drunen C., Denyer J. et al. Inhibition of capsaicin-driven nasal hyper-reactivity by SB-705498, a trpv1 antagonist // Br J Clin Pharmacol. 2014; 77: 777–788.